Equillium Ownership | Who Owns Equillium?
Equillium Ownership Summary
Equillium is owned by 24.33% institutional investors, 35.90% insiders, and 39.77% retail investors. Decheng capital is the largest institutional shareholder, holding 12.55% of EQ shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.60% of its assets in Equillium shares.
EQ Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Equillium | 24.33% | 35.90% | 39.77% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Decheng capital | 4.45M | 12.55% | $3.33M |
Takeda pharmaceutical | 1.82M | 5.15% | $1.37M |
Vanguard group | 841.95K | 2.38% | $629.78K |
Cota capital management | 562.28K | 1.59% | $420.70K |
Renaissance | 261.40K | 0.74% | $195.58K |
Geode capital management | 204.38K | 0.58% | $152.95K |
Acadian asset management | 108.69K | 0.31% | $80.00K |
Callan capital | 99.69K | 0.28% | $74.59K |
Dcf advisers | 62.95K | 0.18% | $47.10K |
State street | 59.72K | 0.17% | $44.68K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Cota capital management | 562.28K | 100.00% | $420.70K |
Takeda pharmaceutical | 1.82M | 5.15% | $1.37M |
Decheng capital | 4.45M | 0.71% | $3.33M |
Dcf advisers | 62.95K | 0.02% | $47.10K |
Callan capital | 99.69K | 0.01% | $74.59K |
Virtu financial | 15.69K | 0.00% | $12.00K |
Renaissance | 261.40K | 0.00% | $195.58K |
Acadian asset management | 108.69K | 0.00% | $80.00K |
Tower research capital llc (trc) | 5.96K | 0.00% | $4.46K |
Commonwealth equity services | 25.00K | - | $19.00K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Susquehanna group, llp | 41.64K | - | 41.64K |
Blackrock | 38.32K | - | 34.51K |
Dcf advisers | 62.95K | 0.02% | 29.98K |
Tower research capital llc (trc) | 5.96K | 0.00% | 5.96K |
Virtu financial | 15.69K | 0.00% | 1.54K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Renaissance | 261.40K | 0.00% | -59.77K |
American century companies | - | - | -40.33K |
Integrated wealth concepts | - | - | -40.00K |
Prudential financial | - | - | -31.20K |
Jane street group | - | - | -19.75K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Tower research capital llc (trc) | 5.96K | 0.00% | 5.96K | $4.46K |
Sold Out
Holder | Change |
---|---|
Lazard asset management | -1.59K |
Simplex trading | -2.09K |
Adar1 capital management | -7.32K |
Citadel advisors | -10.00K |
Ci private wealth | -11.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 25 | -3.85% | 8,659,891 | -0.54% | 24 | 4.03% | 8 | -11.11% | 5 | -16.67% |
Dec 31, 2024 | 12 | -47.83% | 3,030,505 | -56.03% | 8 | 2.26% | 6 | -33.33% | 2 | -33.33% |
Sep 30, 2024 | 23 | -8.00% | 6,892,475 | -2.41% | 19 | 4.85% | 9 | -18.18% | 3 | -25.00% |
Jun 30, 2024 | 25 | -16.67% | 7,062,498 | -0.04% | 20 | 4.84% | 11 | -21.43% | 4 | -50.00% |
Mar 31, 2024 | 30 | 25.00% | 7,065,001 | -6.46% | 20 | 4.34% | 14 | 75.00% | 8 | 33.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 570.84K | 1.60% | - |
Vanguard Total Stock Mkt Idx Inv | 570.84K | 1.60% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 247.43K | 0.69% | - |
Fidelity Extended Market Index | 100.79K | 0.28% | 105.00 |
Mandarine Global Microcap G EUR | 67.50K | 0.19% | 7.50K |
Fidelity Total Market Index | 35.24K | 0.10% | - |
iShares Micro-Cap ETF | 30.43K | 0.09% | - |
Fidelity Series Total Market Index | 24.55K | 0.07% | - |
Fidelity Nasdaq Composite Index | 18.70K | 0.05% | - |
Vanguard Instl Ttl Stck Mkt Idx Tr | 17.86K | 0.05% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 23, 2025 | Keyes Jason A | Chief Financial Officer | Sell | $6.50K |
Nov 14, 2024 | Keyes Jason A | Chief Financial Officer | Sell | $7.00K |
Oct 28, 2024 | Zedelmayer Christine | Sr. Vice President and COO | Sell | $18.75K |
Oct 25, 2024 | Tom Penny | Principal Accounting Officer | Sell | $853.75 |
Oct 28, 2024 | Tom Penny | Principal Accounting Officer | Sell | $3.54K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | - | 1 |
2024 Q4 | - | 4 |
2024 Q3 | - | 3 |
2024 Q2 | - | - |
EQ Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools